Safety of dermatologic medications in pregnancy and lactation: An Update - Part II: Lactation

Marita Yaghi; Patrick McMullan; Thu M Truong; Marti Rothe; Jenny Murase; Jane M Grant-Kels

doi:10.1016/j.jaad.2023.10.071

Safety of dermatologic medications in pregnancy and lactation: An Update - Part II: Lactation

J Am Acad Dermatol. 2024 Jan 25:S0190-9622(24)00110-5. doi: 10.1016/j.jaad.2023.10.071. Online ahead of print.

Authors

Marita Yaghi¹, Patrick McMullan², Thu M Truong³, Marti Rothe¹, Jenny Murase⁴, Jane M Grant-Kels⁵

Affiliations

¹ Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami, Miller School of Medicine, Miami, FL.
² Department of Dermatology, University of Connecticut Health Center, Farmington, CT.
³ School of Medicine, Rutgers New Jersey Medical School, Newark, NJ; Center for Dermatology, Rutgers Robert Wood Johnson Medical School, Somerset, NJ.
⁴ Department of Dermatology, University of California, San Francisco, CA; Palo Alto Foundation Medical Group, Mountain View, CA.
⁵ Department of Dermatology, University of Connecticut Health Center, Farmington, CT; Department of Dermatology, University of Florida, Gainesville, FL. Electronic address: grant@uchc.edu.

PMID: 38280680
DOI: 10.1016/j.jaad.2023.10.071

Abstract

Multiple recently approved medications have been added to our treatment armamentarium for various dermatologic conditions. Herein, we have reviewed the literature, consolidated available safety data, and offered recommendations based upon available evidence as a reference guide for clinicians treating patients for dermatologic conditions during lactation.

Keywords: Janus kinases; acne; antibiotic; antifungal; antihistamines; antipruritics; antiviral; atopic; biologics; breastfeeding; corticosteroid; cosmetics; dermatitis; dermatologic agents; eczema; human; infant; lactation; medication safety; milk; mother; newborn; phototherapy; psoriasis; surgery; wet nursing.

Publication types

Review